EDIT vs LOW
Editas Medicine Inc (EDIT) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
EDIT currently screens at market cap $375.2M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the EDIT and LOW stock pages for the full models.
Not investment advice.